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Abstract
The Fortilin (also known as TCTP) in Penaeus monodon (PmFortilin) and Fortilin Binding Protein 1 (FBP1) have recently been
shown to interact and to offer protection against the widespread White Spot Syndrome Virus infection. However, the
mechanism is yet unknown. We investigated this interaction in detail by a number of in silico and in vitro analyses, including
prediction of a binding site between PmFortilin/FBP1 and docking simulations. The basis of the modeling analyses was well-
conserved PmFortilin orthologs, containing a Ca
2+-binding domain at residues 76–110 representing a section of the helical
domain, the translationally controlled tumor protein signature 1 and 2 (TCTP_1, TCTP_2) at residues 45–55 and 123–145,
respectively. We found the pairs Cys59 and Cys76 formed a disulfide bond in the C-terminus of FBP1, which is a common
structural feature in many exported proteins and the ‘‘x–G–K–K’’ pattern of the amidation site at the end of the C-terminus.
This coincided with our previous work, where we found the ‘‘x–P–P–x’’ patterns of an antiviral peptide also to be located in
the C-terminus of FBP1. The combined bioinformatics and in vitro results indicate that FBP1 is a transmembrane protein and
FBP1 interact with N-terminal region of PmFortilin.
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Introduction
The White Spot Syndrome Virus (WSSV) is a common
pathogen that causes significant production losses in the shrimp
industry around the world. The virus has a wide host range in a
variety of crustaceans, both freshwater and seawater species,
including penaied shrimp, crabs, and crayfish. A WSSV infection
typically causes lethargic behavior, cessation of feeding, a pink to
reddish-brown discoloration, and white inclusion of calcium salts
embedded in the cuticle especially inside the surface of the
carapace. The moribund shrimp swim near the surface at the edge
of ponds. The populations of shrimp showing these signs have high
mortality rates with cumulative mortalities reaching up to 100%
within three to ten days. The transmission of disease is typically via
cannibalism of the sick or dying prawns and directly through
contaminated water. The virus can persist and retain infectivity in
seawater for four to seven days. The histopathology of WSSV
infected shrimp shows severe nuclear hypertrophy, chromatin
margination, and eosinophilic to large basophilic intranuclear
inclusions with variable multifocal necrosis in most tissues of
ectodermal and mesodermal origin [1]. The WSSV also severely
damages the stomach, gills, antennal gland, heart, and eyes. The
infection can be classified into two types: Type I is an acute
infection that causes high mortality within two weeks in species
such as Penaeus monodon, Penaeus indicus, and Penaeus penicillatus. Type
II is latent.
Based on the morphology and the genomic structures, WSSV
has been classified to the genus Whispovirus and the family
Nimaviridae, The virions are enveloped, ovoid to bacilliform
276626 nm long with a diameter of 12169 nm, containing
double-stranded circular DNA with the size ranging from
290 kbp to 305 kbp, which covers approximately 185 open
reading frames, ORFs [1–3]. The virion envelope contains two
major proteins, VP28 and VP19 of estimated sizes 28 and
19 kDa, respectively. The nucleocapsid consists of three major
proteins VP26, VP24 and VP15 of estimated sizes 26, 24, and
15 kDa, respectively [4,5]. A previous study indicates that the
gene identified as ORF390 has anti-apoptotic properties, contains
two putative caspase9 cleavage sites and a caspase3 cleavage site
[6]. The WSSV can replicate and propagate in a number of cell
types, such as haematopoietic cell cultures of freshwater crayfish,
Pacifastacus leniusculus [7], hepatopancreas cells of Penaeus monodon
[8] and ovarian cultures of Marsupenaeus japonicas [9]. The
replication rate of the WSSV inside the nucleus of the
haematopoietic cell cultures of freshwater crayfish is known to
increase with increasing temperature [7].
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33291Over the years, a lot of effort has been put into attempts to
protect against WSSV infection in shrimp, such as the usage of
random library peptides [10], RNA interference, siRNA, VP15
and VP28 genes and long dsRNA — shown to induce both a
sequence-specific and sequence-independent antiviral immunity
[11], injection of VP28-dsRNA alone [12], vaccination with viral
structural proteins and a monoclonal antibody targeting VP28
[13].
Fortilin (also known as Translationally controlled tumor protein,
TCTP) has attracted a lot of attention due to its implication in a
variety of functions, i.e., control of cell cycle, cell growth and cell
division [14,15], microtubule stabilization [16], and as a growth
factor for B-cells [17]. Fortilin is present in both the nucleus and
cytosol [18], is inducible by serum stimulation [19] and heavy
metals [20]. Fortilin has a potent anti–apoptotic function [18,21–
23] through binding interactions with MCL1 (Myeloid cell
leukemia 1) [24] and BCL-XL (B-cell leukemia XL) [25],
belonging to the anti-apoptosis BCL-2 protein family. Fortilin
can also bind to Ca
2+ [26–29] and thus prevent cytosolic Ca
2+
levels from increasing and activating Ca
2+-dependent apoptosis
pathways [28]. Fortilin is thought to be a modulator of GTPase
activity, acting as a molecular switch for a vast number of cellular
processes in all eukaryotes [30]. Fortilin can bind to Na,
K
2ATPase and regulates the function of Na, K
2ATPase in
cooperation with Nexin6 (SNX6) [31]. The Fortilin protein is also
known to be involved in growth and development, it is encoded by
abundant mRNA species, and was initially characterized in mouse
Ehrlich ascites tumor cells and erythroleukemia cells [15,32].
Despite various functions, its wide range of distribution, and high
level of conservation among many organisms, the distinct
functions of Fortilin still remain unclear [16,20,26–28,33].
Our group has previously identified Fortilin in Penaeus monodon,
named PmFortilin (Accession No: AY186580.1) and shown it to
have anti-apoptotic properties. This protein is well conserved,
contains a Ca
2+-binding domain, TCTP signatures similar to that
of the Fortilin or TCTP genes reported in plants and animals [29].
We found it to be present at high levels during an onset of viral
infection in P. monodon and based on a yeast two-hybrid screening
assay and GST-pulldown, we further found Fortilin to interact
with a previously unknown protein, named Fortilin Binding
Protein 1 (FBP1) (Accession No: EU435133.1) [34]. This is a small
peptide of 93 amino acids long with a molecular weight of 11 kDa,
expressed solely in hemocytes and no homologs have yet been
found. It was also of interest that we found transcripts of FBP1 to
be up- regulated during WSSV infection with the highest level
occurring at 48 h post-infection [34]. In this manuscript we report
investigations into the interaction of PmFortilin with FBP1 and its
function. From our results we suggest that FBP1 is a transmem-
brane protein and its likely function is to facilitate transport of
PmFortilin across the cell membrane.
Results
Structural analysis of PmFortilin and FBP1
Experimentally determined structures are not available for
either PmFortilin or FBP1. For this reason, we have predicted the
structures by homology modeling. The best scoring 3-D structure
of PmFortilin contains three sheets, six beta hairpins, two beta
bulges, three helices and one helix-helix interaction. The model
displays one helical domain, stretching from residue 77 to 126 and
one right handed hook (RHH) of the disulphide type (Figure 1).
The model of FBP1 contains two helix domains, 16 beta turns and
12 gamma turns. The two helix domains are located at residues 8
to 21 and residues 23 to 25, forming disulphide bonds between the
Cys59 and Cys76 (Figure 2).
To assess the accuracy of the structure predictions, we
performed a ramachandran analysis, for PmFortilin, 108
(72.50%) residues were in the most favored regions, additional
allowed regions contained 33 (22.10%) residues, generously
allowed regions contained seven (4.70%) residues and disallowed
regions contained only a single (0.70%) residue (Figure S1). For the
predicted FBP1 structure, 31 (49.20%) residues were plotted in the
most favored regions, additional allowed regions contained 21
(33.30%) residues, generously allowed regions contained six
(9.50%) residues and five (7.90%) residues were located in the
disallowed regions (Figure S2).
PmFortilin is highly conserved; the chain A has the solution
structure of human translationally controlled tumor protein, the
chain A with the translationally controlled tumor associated protein
p23fyp from Schizosaccharomyces pombe, the chains A, B, C, and D with
the crystal structure of human translationally controlled tumor
associated protein (hTCTP) mutant E12V, the chain A with the
crystal structure of translationally controlled tumor associated
protein from Plasmodium knowlesi and with the Fortilin structure of
Drosophila melanogaster (PDB ID: 2HR9, 1H6Q, 3EBM, 1TXJ, and
1YZ1 respectively). A further comparison of multiple sequences
reveals that PmFortilincontains conservedregions thatcorrespond to
the helical domain in the predicted 3-D structure. The amino acid
residues 76–110, part of the helical domain of PmFortilin are
contained within a Ca
2+-binding domain, forming a helical domain
between the H2-helix (residues 81–99) and the H3-helix (residues
106–122) producing an EF-hand structure (Figure 1). Importantly, a
small section at the N-terminus (residues 1–10) contains protein
transduction domains (PTDs), 1-MKVFKDMLTG-10, allowing for
the deliveryofactive molecules intothe cells through the lipid bilayer
[35–37]. PmFortilin contains two signature patterns. The TCTP_1
and TCTP_2 at the residues 45–55 and 123–145 with the signatures
‘‘[IFAED]–[GA]–[GASF]–N–[PAK]–S–[GTA]–E–[GDEVCF]–
[PAGEQV]–[DEQGAV]’’ and ‘‘[FLIV]–x(4)–[FLVH]–[FY]–
[MIVCT]–G–E–x(4,7)–[DENP]–[GAST]–x–[LIVM]–[GAVI]–
x(3)–[FYWQ]’’, respectively (Table S1).
For FBP1, we were unable to find homologous sequences in the
existing public databases. However, we used Motif Scan (http://
myhits.isb-sib.ch/cgi-bin/motif_scan) to detect signatures. The
search revealed some interesting signatures: Amino acid residues
4–6 at the N–terminal represented by ‘‘[ST]–x–[RK]’’ pattern at
protein kinase C phosphorylation site and by ‘‘x–G–[RK]–[RK]’’,
which is a known amidation pattern, were found to be located at
the residues 90–93 at the C-terminal end of FBP1 (Table S1). Two
segments of compositionally biased regions or Low Complexity
Regions (LCRs), were located at the amino acid residues 27–48
and 59–87 using SMART server (http://smart.embl-heidelberg.
de) (Table S1 and S2), previously implied in the context of protein-
protein interactions [38–40]. The residues 1–24 are likely to be a
signal peptide (scored 99.00%) with a cleavage site at Ala24 and
Thr25 (scored 87.30%), determined by the Signal P 3.0 server
(http://www.cbs.dtu.dk/services/SignalP). It was of some interest
that FBP1 contains a number of ‘‘x–P–P–x’’ signature sequences
found in antiviral peptides. The longest such pattern is located at
residues 59–76 [34]. In addition, we performed combinatorial
structure analyses using GANGSTA and GANGSTA+ servers
(http://agknapp.chemie.fu-berlin.de/gplus) (Table S3).
Functional analysis of Fortilin/TCTP binding protein
(FBP1)
The predicted 3-D model of FBP1 contains two alpha helix
domains. Such segments are common protein structure elements
A Novel Binding Protein for Pm Fortilin
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and possible localization of FBP1, we utilized HMMTOP (http://
www.enzim.hu/hmmtop) and TMHMM2 servers (http://www.
cbs.dtu.dk/services/TMHMM). According to these predictions,
the helix residues 7–26 are transmembrane segments (Table S1),
the residues 1–6 that correspond to the N-terminal phosphoryla-
tion site found by Motif Scan are located in the cytosol and the
residues 27–93, containing LCRs and ‘‘x–P–P–x’’ signature
sequences, are extracellular (Figure 2B).
To find further support to the hypothesis that the FBP1 is a
transmembrane protein, we transfected Sf9 cells with a plasmid
containing an FBP1-GFP construct. An empty phMGFP plasmid
and mock-transfected cells were used as negative controls.
Confocal laser scanning microscopy was used to observe the
fluorescence patterns in the cells 48 h after transfection.
The signals in the Sf9 cells are clearly located at the plasma
membrane, whereas the signals in the cells transfected only with
GFP are dispersed. The mock-transfected cells show no GFP
signal (Figure 3). In addition plasma membranes stained with 1,19-
Dioctadecyl-3,3,39,39-Tetramethylindocarbocyanine Perchlorate
(DiI) confirmed the localization of FBP1 (Figure 3, lower panel).
The Co-localization of PmFortilin and FBP1 by
immunocytochemistry
Immunofluorescence studies were performed to investigate the
localization of PmFortilin in the presence of FBP1. A confocal laser
Figure 1. The predicted 3-D model and functional mapping of Fortilin from Penaeus monodon. (A) The predicted structure model of
PmFortilin contains six beta hairpins, eleven strands and three helices: The helical domain (helix-helix interaction) along the residues 77–126 and a
flexible loop at residues 38–62. (B) A graphical representation of the functional mapping of PmFortilin protein, was analyzed by SMART and the Motif
Scan server. The following elements are shown: TCTP signatures at residues 45–55 on the flexible loop and 123–145 on the C-terminal, Ca
2+-binding
domain at residues 76–110 and DNA binding domain at residues 80–81, 83–84 and 88 also on the helical domains, serine phosphorylation sites at the
residues 50, 62 and 64, threonine phosphorylation sites at the residues 17, 60 and 103, tyrosine phosphorylation sites at the residues 18, 20, 28 and
92. The ten amino acid residues at the N-terminal show high conservation with the protein transduction domains (PTDs) and may allow trans-
membrane transport.
doi:10.1371/journal.pone.0033291.g001
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in the cells 48 h after transfection. We observed that FBP1-GFP was
located at the plasma membrane (Figure 4A) while the staining with
the anti-PmFortilin antibody appeared in the whole cell (Figure 4B).
According to previous reports, TCTP/Fortilin was mainly localized
inthecytosoland also inthenucleus[14,18].In this experiment,the
co-localization of PmFortilin and FBP1 was detected as a yellow
color only at the plasma membrane (Figure 4C).
PmFortilin/FBP1 docking simulations and interaction
analysis
To further analyze the PmFortilin and FBP1 interaction in
detail, we predicted the PmFortilin/FBP1 binding site residues and
performed docking simulations utilizing the ClusPro 2.0 server
(http://cluspro.bu.edu), including the PIPER docking software
based on the Fast Fourier Transform (FTT) method [41], using
FBP1 as a receptor protein and PmFortilin as a ligand. The models
were predicted using four separate modes: Balance, Electrostatic,
Hydrophobic and VdW+Elec mode. The short interacting
elements were extracted from the best scoring interaction complex
and collected to produce a refined model (Figure 5). The best, i.e.
the lowest docking score of the balance mode is 2993.40 Kcal/
mol and highest 2764.20 Kcal/mol. The average score of the
docking energy center is 2811.29 Kcal/mol and the lowest
docking energy score is 2871.40 Kcal/mol (Table S4). The
electrostatic mode: Lowest docking score is 21,262.30 Kcal/mol
and highest 2990.60 Kcal/mol, the average of the docking energy
center is 21,034.04 Kcal/mol and lowest docking energy score is
21,117.93 Kcal/mol (Table S5), the hydrophobic mode: Lowest
docking score is 21,230.50 Kcal/mol and highest 2951.50 Kcal/
mol, the average docking energy center is 2940.41 Kcal/mol and
the lowest docking energy score is 21,045.73 Kcal/mol (Table S6)
Figure 2. The predicted 3-D model and functional mapping of Fortilin Binding Protein 1. (A) The FBP1 contains two helical domains
located at residues 8 to 21 and residues 23 to 25, forming a disulphide bond between the Cys59 and Cys76. (B) A graphical representation of the
functional mapping of FBP1. The following elements are shown: Two helix domains, 16 beta turns and 12 gamma turns. A signal peptide at residues
1–24, a cleavage site at residues 22–25, with cleavage between Ala24 and Thr25. A protein kinase C phosphorylation site ‘‘[ST]–x–[RK]’’ at residues 4–6
at the N-terminal. An amidation pattern ‘‘x–G–[RK]–[RK]’’ at residues 90–93 at the C-terminal end. Two segments of compositionally biased regions or
Low Complexity Regions (LCRs) at 27–48 and 59–87 and ‘‘x–P–P–x’’ signature sequences of antiviral peptide signatures at 59–76, serine
phosphorylation site at the residue 26, threonine phosphorylation site at the residue 25, tyrosine phosphorylation site at the residue 55.
doi:10.1371/journal.pone.0033291.g002
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2387.90 Kcal/mol and highest 2315.70 Kcal/mol, the average
of docking energy center is 2315.00 Kcal/mol and the lowest
docking energy score obtained is 2340.49 Kcal/mol (Table S7).
According to the docking simulations, the flexible region of
PmFortilin binds to the C-terminus of FBP1. These interactions are
represented in two major conformations A and B (Figure 5A). The
balance mode simulation resulted in 25 separate models. The
conformation A is favored over conformation B with frequencies
18/25 (72.00%) and 7/25 (28.00%) respectively (Figure 5B). Four
of the top five ranking conformations are described in Table S4.
The electrostatic mode yields the frequencies 17/23 (73.91%) and
6/23 (26.09%) for the conformations A and B respectively
(Figure 5C), the hydrophobic mode yields the frequency 6/23
(26.09%) for conformation A and 17/23 (73.91%) for conforma-
tion B (Figure 5D) and the VdW+Elec mode yields the frequencies
22/23 (95.65%) and 1/23 (4.35%) for conformations A and B,
respectively (Figure 5E). The frequencies seem to be in good
agreement, except for the hydrophobic mode, where the
conformation B is the most favored.
These interactions coincide with three domains: (1) the TCTP_1
on the flexible loop of PmFortilin (Figure 6A-left; green color) with
the distance scores of 5.02 and 5.57 respectively for (PmFortili-
n_Ala47)–(FBP1_Try88; FBP1_Asn77), 5.26 and 5.60 for (PmFor-
tilin_Asn48)–(FBP1_Asn77; FBP1_Cys78) and 5.51 for the interac-
tion of (PmFortilin_Ala51)–(FBP1_Pro79). (2) The predicted Ca
2+-
binding domain (Figure 6A-left; orange color) with the distance
score of 4.80 for (PmFortilin_Thr77)–(FBP1_Pro48), 4.72 and 4.70
for (PmFortilin_Gly78)–(FBP1_Pro48; FBP1_Ala49). (3) The TCTP_
2 on the C-terminal of PmFortilin (Figure 6A-left; light blue color)
with the distance scores of 12.31 for (PmFortilin_Gln127)–(FBP1_
Ala51), 9.96 for (PmFortilin_Phe128)–(FBP1_Pro48), 9.74 for
(PmFortilin_Phe129)–(FBP1_Pro48), and 11.59 for (PmFortilin_
Met134)–(FBP1_Pro44), according to the balance mode
(Figure 6B–D).
The docking simulations predict two distinct conformations.
This implies a trimer: FBP1-PmFortilin-FBP1. For this reason, we
performed additional docking simulations, this time simultaneous-
ly using two FBP1s as receptors. In the trimer structure, the Ca
2+-
binding domains and the flexible loop of the PmFortilin structure
interacted as in the dimer (FBP1-PmFortilin) simulations. The
trimer docking simulation based on the balance mode gave the
lowest docking energy score of 21,162.00 Kcal/mol and the
highest 2888.70 Kcal/mol, the average of docking energy being
2986.43 Kcal/mol (Figure 7 and Figure S3A–D).
Yeast two–hybrid assay – N-terminal region of PmFortilin
is responsible for interaction with FBP1
According to the docking simulations, the PmFortilin binds FBP1 at
residues 37–63 located on the flexible loop of the PmFortilin N-
terminus and contacts FBP1 at residues 77–88. To confirm the
docking results, we sub-cloned PmFortilin in three separate fragments:
PmFT1 (residues 1–70), PmFT2 (residues 71–120) and PmFT3
(residues 121–168). The interaction of FBP1 with each of the three
fragments was tested by the yeast two-hybrid assay. The yeast growth
in YPDA was monitored to ensure that there were no growth defects
in all recombinant clones (Figure 8A). After co-transformation, the
clones that harbored the binding proteins were selected from a
selective medium, at this step there were no clones found from the
yeast harboring BD-PmFT2+ AD-FBP1 (Table 1). This indicated that
these two proteins did not interact with each other. The b-
galactosidase filter assay was then used to test the yeast harboring
BD-PmFT1+AD-FBP1 and that harboring BD-PmFT3+AD-FBP1.
The result confirmed an interaction only for BD-PmFT1+AD-FBP1,
thereby supporting the docking results (Figure 8B). Further investiga-
tions are required to understand the binding of PmFortilin and FBP1.
Discussion
In previous report FBP1 was identified and cloned from the
library by yeast two hybrid screening using PmFortilin as the bait.
Figure 3. Transmembrane localization of FBP1-GFP in Sf9 cell.
The cellular localization of FBP1-GFP expressed in Sf9 cell was observed
using confocal laser scanning microscopy at 48 h post-transfection. The
plasma membrane was stained with DiI (Invitrogen) and shows co-
localization of both fluorescent (green for GFP and red for DiI) after merging.
Bright field is shown in the last panel. The scale bars indicate 10 mm.
doi:10.1371/journal.pone.0033291.g003
Figure 4. Live-cell and confocal imaging of the subcellular co-
localization of GFP-FBP1 and PmFortilin. After co-transfection
(48 h), the sf9 cells were fixed with paraformaldehyde and stained with
rabbit anti-PmFortilin antibody, followed by Alexa Fluor 647-conjugated
goat anti-rabbit IgG antibody (Invitrogen). The cells were observed with
a confocal laser scanning microscope. The scale bars indicate 10 mm.
doi:10.1371/journal.pone.0033291.g004
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down [34]. Both PmFortilin and FBP1 transcripts have been show
to be up regulated during a viral infection, thus implying a role in
a defense mechanism against viruses. Here we try to accelerate a
way to design proper biochemical experiments for the functional
analysis of a novel gene product, FBP1 by using in silico methods.
We have identified FBP1 as a membrane binding protein and
analyzed its interaction with PmFortilin. The prediction was
supported by the co-localization of Fortilin and FBP1 at the same
position on plasma membrane. The contact sites of PmFortilin are
Figure 5. Molecular interaction models of PmFortilin/FBP1. (A top) A space-filling model representing the combination of two possible
interactions of FBP1 (grey), at the opposite sides of PmFortilin (blue). (A bottom) A cartoon of the space-filling model showing the two conformations,
A and B and the binding of PmFortilin to the C-terminus of FBP1. The predictions were performed with four separate modes: Balance, Electrostatic,
Hydrophobic and VdW+Elec mode. (B–E) The lowest energy conformations of each of the four docking modes. The PmFortilin molecule (blue) and
FBP1 (pink, yellow, magenta and green).
doi:10.1371/journal.pone.0033291.g005
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loop of PmFortilin that contains the TCTP_1. The contact sites of
FBP1 are located at the amino acid residues 44–51 and 77–88.
The C-terminal of FBP1 is located outside of the cell membrane
and contains the Cys59 and Cys76 pair forming a disulfide bond,
which together with the LCRs of FBP1 and the N-terminal of
PmFortilin facilitates a high-affinity binding to FBP1. The possible
function of the ‘‘x–G–K–K’’ feature at the amidation site of FBP1
is to protect the C-terminus from being modified by proteases.
Further investigation by using site directed mutagenesis at the
predicted locations are required to support this conclusion.
In addition to the above analysis results, given that the signal
peptides and transmembrane helixes contain hydrophobic amino
acids, the existence of an N-terminal phosphorylation site and the
cleavage site at Ala24 and Thr25, the results indicate that the
function of FBP1 is to facilitate the transport of PmFortilin through
Figure 6. Transmembrane topology and PmFortilin/FBP1 interaction complex. (A left) The FBP1 protein integrated with the cell membrane,
bound with PmFortilin. The residues 1–6 are intracellular, the residues 7–26 include the transmembrane segment and the residues 27–93 are
extracellular, binding to PmFortilin. Ca
2+-binding domain is shown in the orange color, the TCTP_1 on the flexible loop is in green, the TCTP_2 on the
C-terminal is in light blue and other residues are in blue. (A right) A cartoon of the PmFortilin interaction complex, the FBP1 binding to PmFortilin and
integration with the cell membrane; the PmFortilin (blue oval), the amidation site (light green), the cleavage site (light blue hexagon), the
phosphorylation site (yellow), and the blue regions denote the binding regions of FBP1 at amino acid residues Pro44–Ala51 and Asn77–Ala80, Tyr88.
This is according to the best of the interaction with the balance mode docking (probability is 72.00%). (B) The distances of amino acids in TCTP_1
interacting with the C-terminus of FBP1: Ala47 of PmFortilin and Asn77, Try88 of FBP1 and, Asn48 of PmFortilin and Asn77, Cys78 of FBP1, and Ala51
of PmFortilin and Pro79 of FBP1. (C) The distances in Angstroms between adjoining amino acids between the PmFortilin Ca
2+-binding domain and
FBP1: Thr77 of PmFortilin and Pro48 of FBP1, Gly78 of PmFortilin and Pro48, Ala49 of FBP1. (D) The distances of amino acids in the TCTP_2 interaction
with the C-terminus of FBP1: Gln127 of PmFortilin and Ala51 of FBP1, Phe128–129 of PmFortilin and Pro48 of FBP1, Met134 of PmFortilin and Pro44 of
FBP1.
doi:10.1371/journal.pone.0033291.g006
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indicate that PmFortilin can bind two FBP1s simultaneously and
thus may be active as a trimer. However, further investigations are
needed to decipher the detailed mechanism of transport,
phosphorylation and cleavage.
Materials and Methods
Molecular modeling
The homology modeling for the 2-D and 3-D structures were
performed with SWISS-MODEL [42] and I-TASSER [43]. The
best template was automatically selected based on multiple-
threading simulations and used for the structural model. Each of
the predicted models was validated based on the best scoring
model given by the PROCHECK software [44]. These were
evaluated by ramachandran plot analysis utilizing ProFunc [45]
(http://www.ebi.ac.uk/thornton-srv/databases/profunc) and
PROCHECK software. The 3-D template structures were
brought from the PDB database (http://swissmodel.expasy.org).
Functional and molecular homology analysis
The GANGSTA and GANGSTA+ [46] were used for
comparisons of the 3-D structures of PmFortilin and FBP1. Motif
Scan [47] and SMART [48] were used for scanning signature
domains of the PmFortilin and FBP1 with the default parameters,
including outlier homologs and homologs of known structures,
Pfam domains, signal peptides, internal repeats and intrinsic
protein disorder databases.
The ProFunc server was used to identify the potential functions
within the 3-D structures. The HMMTOP [49] with the ‘reliable’
mode and Baum-Welch iteration and TMHMM servers [50] were
utilized to predict helical transmembrane segments and the
topology with default parameters. Signal peptides and cleavage
site patterns were predicted using the SignalP server [51], trained
on eukaryotes. Multiple sequence alignments were constructed by
using Clustal [52].
Molecular docking simulations and analysis of the
interaction model
The molecular interaction and docking simulations were
performed using the ClusPro 2.0 server [53]. The interaction
Figure 7. The PmFortilin/FBP1 trimer (FBP1-PmFortilin-FBP1)
interaction complex. The Ca
2+-binding domain (orange) and the
TCTP_1 of the flexible loop (green). The trimer docking simulation
based on the balance mode yielded the lowest docking energy score of
21,162.00 Kcal/mol, the highest 2888.70 Kcal/mol and the average
docking energy of 2986.43 Kcal/mol.
doi:10.1371/journal.pone.0033291.g007
Figure 8. The yeast two–hybrid assay. The yeast two-hybrid interaction between PmFortilin fragments and FBP1 in S.cerevisiae AH109 cells.
(A)YPDA control to show yeast growth. (B) b-galactosidase activity of the yeast cultures in selective medium determined by a colony-lift filter assay.
doi:10.1371/journal.pone.0033291.g008
Table 1. Summary of the growth of yeast harboring
recombinant plasmids.
Yeast harboring plasmids YPDA Selective medium
BD-FT1 + AD-FBP1 ++++ ++++
BD-FT2 + AD-FBP1 ++++ 2
BD-FT3 + AD-FBP1 ++++ +++
+ , the growth was observed within 3 days; 2, no growth.
doi:10.1371/journal.pone.0033291.t001
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energy values were extracted and collected for simulation. The
model of the interaction complex was assessed by the root mean
square deviation (RMSD) value and the top ranking, i.e. the
lowest docking energy score was used to build the construct of
the interaction model. The molecular surfaces and protein
structure models in the figures are built and visualized with the
PyMOL [54] software on the BioSLAX suite (http://www.
bioslax.com).
Construction of recombinant FBP1-GFP and confocal
microscopy
FBP1 was cloned into the phMGFP vector (Promega, catalogue
no. E6421) to generate an FBP1-GFP fusion protein. PCR was
performed with forward primer FBP1-F: 59-GCTAGCAT-
GAAGTTCTCATGT; containing NheI site and reverse primer
FBP1-R: 59-CCCGGGCTTCTTGCCCTTACT; containing the
XmaI site without the stop codon at its C-terminal. The fragments
were blunt-end inserted into phMGFP amplified by transforma-
tion into the high efficiency Escherichia coli Top10F’competent
(Invitrogen) by the heat shock method. The plasmids were
extracted and purified with QIAprep Spin Miniprep Kit (Qiagen).
The Sf9 cells were seeded at a density of 5610
5 cells onto the
cover slips in Sf9-S2 medium (PPA). The phMGFP and phMGFP-
FBP1 plasmids were transfected into Sf9 cells using Transfast
TM
Transfection reagent (Invitrogen) according to the product
instructions and cultured in a 28uC incubator. After 48 h of
transfection, the cells were washed by PBS twice. The plasma
membrane was stained with 2 mM DiI (Invitrogen) for 15 min at
4uC and the Sf9 cells were observed directly with the confocal laser
scanning microscope.
Localization of PmFortilin in the presence of FBP1 by
immunocytochemist
Sf9 cells, at a density of 5610
6 cells, were grown on glass
coverslips in Sf9-S2 medium (PPA), then cotransfected with
phMGFP-FBP1 and pCDNA-PmFortilin using Transfast
TM
Transfection reagent (Invitrogen) according to the product
instructions. Cells were cultured in a 28uC incubator. 48 h post-
transfection, the cells were washed twice with phosphate-buffered
saline (PBS) and fixed with 4% paraformaldehyde for 10 min
followed by washing with 0.1% Triton x-100 in PBS for 3 min at
4uC. Fixed cells were washed again with PBS before blocking with
5% skim milk at 4uC for 1 h. After incubating, cells were washed
and incubated with specific rabbit anti-PmFortilin antibody
(dilution of 1:500 in PBS) at 4uC for 16–18 h. The cells were
washed 3 times with PBST and incubated with Alexa flour 647-
conjugated goat anti-rabbit IgG antibody (Invitrogen, 1:1,000 in
PBS) at room temperature for 2 h. After washing 3 times with
PBST, the cover glasses were mounted with 10% glycerol in PBS.
The fluorescence signal was detected using a confocal laser
scanning microscope (Olympus FV300).
Yeast two-hybrid assay
The yeast two-hybrid screens were performed with the Clontech
Matchmaker GAL4 Two-Hybrid System 3 (Clontech Laborato-
ries, Inc., Mountain View, CA, USA). PmFortilin was divided into
3 fragments: PmFT1 (residues 1–70), PmFT2 (residues 71–120) and
PmFT3 (residues 121–168). Plasmids pGBKT7 (named BD
vectors) were used for construction of BD-PmFortilin. The
plasmids were constructed by inserting into EcoRI and SalI sites
on a BD-bait vector. Each fragment was amplified by PCR using
the following primers;
BD-PmFT1:
BD-PmFT1-F: 59-CGGAATTCATGAAGGTCTTCAAG,
BD-PmFT1-R: 59-GCGTCGACTCATATAACTACATCAA-
CAC
BD-PmFT2:
BD-PmFT2-F: 59-GGAATTCTATATGCGTCTGCAGGAAAC,
BD-PmFT2-R: 59-GCGTCGACTCACAAAAGGTCTGTCA
and BD-PmFT3:
BD-PmFT3-F: 59-CGGAATTCAAGAAGTTCAAG-
GACTTGCA,
BD-PmFT3-R: 59-GCGTCGACTTATAGCTTCTCCTCTGT.
The plasmid pGADT7 (named AD vector) was used for
construction of the AD-FBP1 and contained the BamHI and XhoI
sites;
AD-FBP1:
AD-FBP1-F: 59-GGATCCCGATGAAGTTCTCATG-
TAAAGT,
AD-FBP1-R: 59-CCCTCGAGTTACTTCTTGCCCTTAC-
TAT.
All plasmids constructed were verified by sequencing.
Competent yeast cells, Saccharomyces cerevisiae strain AH109 were
co-transformed either with BD-PmFT1 and AD-FBP1, BD-
PmFT2 and AD-FBP1, BD-PmFT3 and AD-FBP1. Cells were
then spread on SD selective medium lacking tryptophan,
leucine, histidine and adenine (SD-TLHA). The plates were
incubated at 30uC until positive colonies were visible after 2–4
days. The transformations were confirmed by PCR. The
positive clones were in addition assayed by a filter lift b-
galactosidase assay for LacZ activity as described in the
manufacturer’s protocols.
Supporting Information
Figure S1 The ramachandran analysis of the Fortilin model
from Penaeus monodon. The number of residues in most favored
regions [A, B, L] is 108 (72.50%), the number of residues in
additional allowed regions [a, b, l, p] is 33 (22.10%), the number of
residues in generously allowed regions [,a, ,b, ,l, ,p] is 7
(4.70%) and one (0.70%) residue in disallowed regions. The
number of non-glycine and non-proline residues is 149 (88.69%),
the number of end-residues (excl. Gly and Pro) is 2 (1.19%), the
number of glycine residues (shown as triangles) is 11 (6.55%) and
the number of proline residues is 6 (3.57%).
(TIF)
Figure S2 The ramachandran analysis of the FBP1 model. The
number of residues in most favoured regions [A, B, L] is 31
(49.20%), the number of residues in additional allowed regions [a,
b, l, p] is 21 (33.30%), the number of residues in generously
allowed regions [,a, ,b, ,l, ,p] is 6 (9.50%), the number of
residues in disallowed regions is 5 (7.90%). The number of non-
glycine and non-proline residues is 63 (67.74%), the number of
end-residues (excl. Gly and Pro) is 2 (2.15%), the number of
glycine residues (shown as triangles) is 3 (3.23%) and the number
of proline residues is 25 (26.88%).
(TIF)
Figure S3 Multimer simulations of PmFortilin/FBP1 interac-
tion model, based on balance mode, FBP1 as the receptor and
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monomer combined with two PmFortilin molecules (1:2), yields
the lowest docking energy of 2913.00 Kcal/mol. (B) FBP1
monomer combined with three PmFortilins (1:3), yields the
lowest docking energy of 21,244.80 Kcal/mol. (C) Two FBP1
molecules combined with two PmFortilins (2:2), yields the lowest
docking energy of 21,015.80 Kcal/mol. (D) Two FBP1
molecules and three PmFortilins (2:3), yields the lowest docking
energy of 21,015.80 Kcal/mol. The Ca
2+-binding domain
orange color and the TCTP signature 1 of the flexible loop is
green.
(TIF)
Table S1 The SMART and Motif Scan analysis for PmFortilin
and FBP1.
(DOCX)
Table S2 The SMART analysis result of FBP1 on the SMART
database.
(DOCX)
Table S3 The 3D structure alignment of FBP1 on ASTRAL40
database (version 1.75).
(DOCX)
Table S4 List of the balance mode docking simulation of
PmFortilin/FBP1.
(DOCX)
Table S5 List of the electrostatic mode docking simulation of
PmFortilin/FBP1.
(DOCX)
Table S6 List of the hydrophobic mode docking simulation of
PmFortilin/FBP1.
(DOCX)
Table S7 List of the VdW+Elec mode docking simulation of
PmFortilin/FBP1.
(DOCX)
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